Zhou et al. describe an antiviral strategy for herpes simplex encephalitis that employs enucleated MSCs overexpressing Nectin-1 as decoys. This strategy effectively sequesters the virus and prevents its intracellular replication. Ultimately, they undergo programmed apoptosis, thereby facilitating macrophage-mediated clearance. This strategy offers a therapeutic approach for refractory viral infections.